Table 5.
Comparison of the mean ± S.E of the haematological parameters after 25 days of HAART administration with the control group.
| Parameter | Group A 0 mg/Kg |
Group B 3 mg/Kg |
Group C 6 mg/Kg |
Group D 12 mg/Kg |
Group E 24 mg/Kg |
|---|---|---|---|---|---|
| RBC (×1012/L) | 7.52 ± 0.69 | 8.47 ± 0.16 | 8.95 ± 0.20 | 6.78 ± 1.03 | 6.42 ± 0.75 |
| HB (g/dL) | 14.55 ± 1.05 | 14.50 ± 0.10 | 16.20 ± 0.50 | 12.60 ± 2.20 | 11.55 ± 1.35 |
| PCV (L/L) | 53.20 ± 3.10 | 52.40 ± 0.40 | 59.60 ± 2.70 | 44.10 ± 8.10 | 40.05 ± 4.75 |
| MCHC (g/dL) | 27.50 ± 0.50 | 28.00 ± 1.00 | 27.50 ± 0.50 | 28.85 ± 0.45 | 28.90 ± 0.10 |
| MCV (fL) | 71.20 ± 2.20 | 62.50 ± 1.50 | 66.70 ± 4.50 | 64.50 ± 2.50 | 62.65 ± 0.35 |
| MCH (pg) | 19.40 ± 0.40 | 39.30 ± 21.70 | 18.15 ± 0.95 | 18.55 ± 0.45 | 18.00 ± 1.00 |
| RETICS (%) | 0.90 ± 0.10 | 1.20 ± 0.10 | 1.30 ± 0.10 | 1.10 ± 0.10 | 1.35 ± 0.05 |
| PLAT (×109/L) | 624.50 ± 113.50 | 798.50 ± 3.50 | 791.00 ± 29.00 | 815.00 ± 26.00 | 798.50 ± 13.05 |
| WBC (×109/L) | 10.75 ± 0.15 | 8.25 ± 0.65 | 8.80 ± 2.70 | 8.40 ± 0.30* | 7.30 ± 0.80* |
| NEUT (%) | 28.00 ± 8.00 | 7.50 ± 1.50 | 13.50 ± 5.50 | 17.50 ± 4.50 | 7.50 ± 0.50 |
| LYMPH (%) | 72.00 ± 8.00 | 92.50 ± 1.50 | 86.50 ± 5.50 | 81.00 ± 5.00 | 92.50 ± 0.50 |
| EOS (%) | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
| MONO (%) | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 1.50 ± 0.50 | 0.00 ± 0.00 |
| BAS (%) | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
RBC: red blood cell, HB: haemoglobin concentration, PCV: packed cell volume, MCHC: mean cell haemoglobin concentration, MCV: mean cell volume, MCH: mean cell haemoglobin, RETICS: reticulocytes, PLAT: platelets, WBC: white blood cell, NEUT: neutrophils, LYMPH: lymphocytes, EOS: eosinophils, BAS: basophils.
*Compared with the control group *P < 0.05.